Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions

被引：0
|
作者：
Mehilli, Julinda
Ndrepepa, Gjin
Kastrati, Adnan
Neumann, Franz-Josef
ten Berg, Jurrin
Bruskina, Olga
Dotzer, Franz
Seyfarth, Melchior
Dirschinger, Josef
Pache, J. rgen
Berger, Peter B.
Schömig, Albert
机构：
[1] Deutsch Herzzentrum Munich, Munich, Germany
[2] Duke Clin Res Inst, Durham, NC USA
[3] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-8000 Munich, Germany
[4] St Antonius Hosp, Nieuwegein, Netherlands
[5] Herz Zentrum Bad Krozingen, Bad Krozingen, Germany
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：812 / 813
页数：2
相关论文
共 50 条
  • [1] Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions
    Ndrepepa, Gjin
    Kastrati, Adnan
    Mehilli, Julinda
    Neumann, Franz-Josef
    ten Berg, Jurrien
    Bruskina, Olga
    Dotzer, Franz
    Seyfarth, Melchior
    Pache, Juergen
    Dirschinger, Josef
    Ulm, Kurt
    Berger, Peter B.
    Schoemig, Albert
    CIRCULATION, 2006, 114 (19) : 2040 - 2046
  • [2] Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions:: Results from intracoronary stenting and antithrombotic regimen:: Rapid early action for coronary treatment 2 trial
    Mehilli, Julinda
    Ndrepepa, Gjin
    Kastrati, Adnan
    Neumann, Franz-Josef
    ten Berg, Jurrien
    Bruskina, Olga
    Dotzer, Franz
    Seyfarth, Melchior
    Pache, Juergen
    Kufner, Sebastian
    Dirschinger, Josef
    Berger, Peter B.
    Schomig, Albert
    AMERICAN HEART JOURNAL, 2007, 154 (01) : 158.e1 - 158.e7
  • [3] Prognostic significance of small vessel coronary artery disease in patients with acute coronary syndromes treated with percutaneous coronary interventions
    Kampka, Zofia
    Drabczyk, Mateusz
    Zak, Magdalena
    Mizia-Stec, Katarzyna
    Wybraniec, Maciej T.
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2023, 19 (01): : 14 - 21
  • [4] The radial approach allows a 4-fold decrease in bleedings in percutaneous coronary interventions with abciximab for acute coronary syndromes
    De Carlo, M
    Bini, R
    Cortese, B
    Borelli, G
    Gherarducci, G
    Ciabatti, N
    Balbarini, A
    Petronio, AS
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 120H - 120H
  • [5] Very Elderly Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention
    Wong, Bernard
    Lee, Kyu-Hyun
    El-Jack, Seif
    HEART LUNG AND CIRCULATION, 2021, 30 (09): : 1337 - 1342
  • [6] Radial Versus Femoral Accesses for Percutaneous Coronary Interventions in Patients with Acute Coronary Syndromes
    Omerovic, E.
    Haraldsson, I
    CARDIOLOGY, 2013, 125 : 20 - 20
  • [7] Radial versus Femoral Accesses for Percutaneous Coronary Interventions in Patients with Acute Coronary Syndromes
    Omerovic, Elmir
    Omerovic, Elmir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B96 - B96
  • [8] Abciximab as an adjunctive therapy for patients undergoing percutaneous coronary interventions
    Parikh, Devang
    Juergens, Craig P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) : 235 - 246
  • [9] Comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary interventions
    Changezi, H
    Schweiger, MJ
    Prescod, D
    Cook, JR
    CIRCULATION, 1999, 100 (18) : 187 - 187
  • [10] Bleeding complications after percutaneous coronary interventions in patients treated with abciximab in relation to dose of clopidogrel
    Kazmierski, Maciej
    Wieczorek, Piotr
    Ochala, Andrzej
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2009, 5 (04): : 172 - 175
12345